First experience with a new drug-eluting balloon for the treatment of congenital pulmonary vein stenosis in a neonate

Cardiol Young. 2010 Aug;20(4):455-8. doi: 10.1017/S1047951110000703. Epub 2010 Jun 2.

Abstract

Paclitaxel-eluting balloons are a new and innovative method in the treatment of in-stent stenosis and small vessel disease in adult cardiac pathology. The treatment of congenital pulmonary vein stenosis is difficult to manage, and results in a high mortality rate due to residual or recurrent stenosis. We report the first case of treatment for neonatal pulmonary vein restenosis with a paclitaxel-eluting balloon.

Publication types

  • Case Reports

MeSH terms

  • Age Factors
  • Catheterization / instrumentation*
  • Drug-Eluting Stents*
  • Humans
  • Infant, Newborn
  • Paclitaxel / adverse effects
  • Pulmonary Valve Stenosis / congenital*
  • Pulmonary Valve Stenosis / diagnosis
  • Pulmonary Valve Stenosis / therapy*
  • Tubulin Modulators / adverse effects

Substances

  • Tubulin Modulators
  • Paclitaxel